← Previous Post: | Next Post:

 

“Payers will no longer pay rising prices for marginally improved new products and pharmas must now justify those higher prices by demonstrating substantially greater benefits. That means new drug development requires more time and cost to make the case for improved cost-benefit and, more often than not, the effort fails. As a result the sales revenues for new drugs suffer both initially and over time. Then in their insatiable demand to maintain a profitability that exceeded all other industries over the past thirty years, pharmas have turned to the emerging countries as their golden goose. There local conditions and the inexorable greed of pharma companies combine to produce a way of doing business that is intrinsically corrupt.”

In case you were wondering why pharma is intrinsically corrupt. And will remain so. After all, this writer didn’t even mention pharma’s impressive capacity to make up bogus ailments, frighten the shit out of us about them, and provide pills.

Margaret Soltan, April 19, 2014 11:11AM
Posted in: merchandise

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=43826

Comment on this Entry

Latest UD posts at IHE

Archives

Categories